ArticleCommunications biology2023

Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate.

Shuai Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.